Number of the records: 1
inhibítory vazopeptidáz
SYS d000075563 LBL 00000cx^^^2200181-^^45^^ 005 20240119195320.2 100 $a 20180101asloy0103 ba0 152 $b mesh 250 $a inhibítory vazopeptidáz $x AA $x AD $x AE $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo 300 1-
$a 2018 $8 eng 300 1-
$a Angiotensin-Converting Enzyme Inhibitors (1999-2017) $8 eng 300 1-
$a Neprilysin/antagonists and inhibitors (1999-2017) $8 eng 330 1-
$a A class of cardiovascular drugs indicated for hypertension and congestive heart failure that simultaneously inhibit both NEUTRAL ENDOPEPTIDASE and ANGIOTENSIN CONVERTING ENZYME. They increase the availability of NATRIURETIC PEPTIDES and BRADYKININ and inhibit production of ANGIOTENSIN II. $8 eng 450 $a Vasopeptidase Inhibitor $5 e $8 eng 450 $a inhibítor vazopeptidáz $5 e $8 slo 450 $a ACE-NEP inhibítory $5 e $8 slo 450 $a NEP-ACE inhibítory $5 e $8 slo 450 $a inhibitory ACE a NEP, duálne $5 e $8 slo 686 $a D27.505.519.389.745.085.500 750 $a Vasopeptidase Inhibitors $8 eng 801 -0
$a SK $b BA006 $c 20180615 801 -2
$a SK $b BA006 $c 20181105 801 -2
$a SK $b BA006 $c 20220623 980 $x M
Number of the records: 1